Mineral ·Emerging evidence ·Reviewed May 2026
Trace mineral that enhances insulin sensitivity and supports healthy blood sugar metabolism. Popular supplement for glucose management and body composition.
The bottom line
Evidence rating emerging. Most-documented uses: blood sugar support, insulin sensitivity, appetite control. 17 sources indexed (2004–2024), with 28 interaction records on file.
Core mechanism
Potentiates insulin action by enhancing insulin receptor signaling via chromodulin (low-molecular-weight chromium-binding substance). Increases GLUT4 transporter translocation to cell membranes, facilitating glucose uptake.15,6
Take with meals; picolinate form has best bioavailability1,2
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Chromium Picolinate.
Assumes 200-500 mcg/day from goal dosage. Vendor basis: NOW/iHerb, Vitacost, Life Extension, and Amazon marketplace; standalone chromium remains low cost. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Food chromium content is variable and hard to estimate precisely.
The AI is far lower than common supplement doses.
Timing: With meals
Best used when carb-heavy meals or insulin resistance are part of the picture.
Dose: 200-400 mcg daily
Timing: With breakfast or lunch
Use as an adjunct to dietary structure, not a substitute.
Dose: 200-1,000 mcg daily17
Timing: Split with meals if using higher amounts
More is not always better; many people do well at the low end.
What to test, the optimal window inside the conventional range, and how long a response takes.
Chromium picolinate may modestly lower HbA1c in type 2 diabetes (meta-analyses show roughly 0.3 to 0.5 percent reduction); effect in non-diabetics is small.1,3
Direct serum chromium is unreliable. Use HbA1c and fasting glucose to monitor metabolic effect.
Chromium is expected to modestly lower fasting glucose mainly in type 2 diabetes, with effects that are typically small, dose-dependent, and clearest when glucose is elevated and chromium status is inadequate at baseline.3,14
Requires an 8 to 12 hour overnight fast. Keep timing consistent and note diet, illness, and concurrent glucose-lowering medications as confounders. Effects are inconsistent in people with normal glucose. Retest after about 12 weeks.
Chromium may modestly lower fasting insulin by improving how cells respond to insulin. The proposed mechanism is that chromium may help support insulin receptor signaling and glucose uptake, though this is not firmly established. The evidence is emerging and mixed: trials show the most consistent benefit in people with insulin resistance or type 2 diabetes, while results in metabolically healthy individuals are often small or absent, so any effect should be considered preliminary.3,6
Draw the sample in the morning after an 8 to 12 hour overnight fast, ideally before your morning supplements, and keep the testing conditions (lab, assay, time of day, and recent diet and activity) as consistent as possible between draws, since fasting insulin assays vary widely between labs. Pairing chromium with regular physical activity and a diet lower in refined carbohydrate tends to influence insulin sensitivity far more than the supplement alone. Because fasting insulin is closely tied to glucose regulation and diabetes risk, involve a clinician before starting if you have diabetes, prediabetes, or take any glucose-lowering or insulin medication, as combined effects could push values lower than expected and require dose adjustment and monitoring.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Chromium supports insulin signaling and modestly reduces carbohydrate cravings in small RCTs, particularly in atypical depression.6,15
Effect is small; pair with protein-forward meals.
Chromium supports insulin signaling and is commonly used when carb-heavy meals trigger swings.2,3
Best when diet and sleep are also addressed.
Chromium may enhance insulin sensitivity and help smooth post-meal glucose swings, though effects on reactive hypoglycemia specifically are modest and inconsistent.1,2
Supportive only; recurrent or severe crashes warrant clinical evaluation to rule out underlying causes.
Chromium contributes to insulin action and may modestly improve fasting glucose, with larger effects when baseline intake or status is low.6,1
Trial results are inconsistent; consider it a minor adjunct rather than a core intervention.
Chromium may potentiate insulin action by supporting receptor signaling, with modest and inconsistent glycemic effects across trials.15,6
Benefit is most likely in deficiency states, and routine large doses show limited additional value.
May potentiate insulin action and modestly improve fasting glucose, though effects on PCOS endpoints are inconsistent.15,6
Benefit is modest; not a substitute for diet or the more established insulin-sensitizers.
Chromium supports insulin signaling, and a few small trials suggest it may modestly reduce carbohydrate cravings, though results are inconsistent.4,6
Effect sizes are small; treat it as a minor adjunct, not a primary strategy.
Chromium may influence insulin sensitivity and appetite regulation, with small and inconsistent effects on body composition.7,12
Any appetite or weight effect is minor, and it is most useful where insulin handling is impaired.
Chromium may enhance insulin action and support more stable blood glucose, which could theoretically blunt post-meal energy dips, but this is unproven in healthy people.1,2
Evidence for energy or glucose stability in non-diabetics is weak; address meal composition and post-lunch glucose swings first.
Chromium may reduce carbohydrate cravings and stabilize glucose, indirectly supporting appetite control.1,6
Trials show small and inconsistent effects on appetite and weight; best viewed as a minor adjunct to diet and protein intake.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
Chromium picolinate modestly lowers HbA1c in T2D; useful adjunct rather than primary therapy.5,11
Chromium is a trace mineral that may play a supporting role in insulin signaling and post-meal glucose handling, which some studies tentatively link to reduced carbohydrate cravings. Trial results on appetite and weight are mixed and effect sizes are small, so any benefit should be viewed as modest and supportive.1,4
Both lower blood glucose through different mechanisms. Combined use may cause excessive blood sugar reduction, especially in non-diabetics.
Recommendation: Monitor blood glucose closely if combining. May need to reduce doses. Consult healthcare provider if on diabetes medication.
Vitamin C enhances chromium absorption by reducing Cr3+ in the gut, making it more bioavailable.
Recommendation: Take chromium with vitamin C for improved absorption. 200mcg chromium + 500mg vitamin C.
Vitamin C Liposomal enhances chromium absorption by reducing Cr3+ in the gut, making it more bioavailable.
Recommendation: Take chromium with vitamin C for improved absorption. 200mcg chromium + 500mg vitamin C.
Both lower blood glucose through different mechanisms. Combined use may cause excessive blood sugar reduction, especially in non-diabetics.
Recommendation: Monitor blood glucose closely if combining. May need to reduce doses. Consult healthcare provider if on diabetes medication.
Vanadium and chromium both have insulin-sensitizing, glucose-lowering activity, so combining them can produce additive reductions in blood glucose and risk of hypoglycemia, particularly in people on diabetes medication.
Recommendation: Avoid stacking unless supervised by a clinician. People taking antidiabetic drugs should monitor blood glucose closely and watch for signs of hypoglycemia.
Myo-inositol and chromium each support insulin sensitivity through different routes, so combining them may give additive benefit on fasting insulin and glycemic control in insulin-resistant states such as PCOS.
Recommendation: Reasonable to combine for insulin resistance. Common amounts are myo-inositol 2g to 4g daily with chromium (as picolinate) 200mcg to 1000mcg daily; monitor glucose if also taking diabetes medication.
Combining chromium with alpha-lipoic acid may improve insulin sensitivity and cellular glucose uptake more than either taken alone.
Recommendation: Reasonable to take together for glycemic support. If you use blood-glucose-lowering medication, monitor for additive lowering and discuss dosing with your clinician.
Chromium picolinate combined with biotin (vitamin B7) has improved fasting glucose and glycemic markers more than chromium alone in studies of impaired glucose control.
Recommendation: The two are commonly paired and can be taken together for glycemic support. Not a substitute for prescribed diabetes therapy.
Chromium and magnesium each support insulin signaling, so adequate status of both is associated with better insulin sensitivity than low status of either.
Recommendation: Reasonable to take together for metabolic support. No timing restriction is needed.
CLA (specifically the t10,c12 isomer in standard 50:50 supplements) has documented potential to reduce insulin sensitivity, while chromium is taken to improve it. Because both are commonly bundled in weight-management and fat-loss stacks, this opposition is clinically relevant rather than theoretical. The interaction matters most for people with prediabetes, type 2 diabetes, or metabolic syndrome, where unexpected swings in glycemic control carry real consequences.
Recommendation: If you are using chromium to support glucose control, be cautious stacking it with high-dose mixed CLA (3 to 6 g/day). They can be taken in the same day, but monitor fasting glucose or use a glucometer or CGM during the first few weeks of combining them. People with insulin resistance, prediabetes, or diabetes should consult a clinician before pairing them. Consider an isomer-specific CLA (predominantly c9,t11), which has not shown the same insulin-impairing signal, or prioritize chromium and drop CLA if glycemic control is the goal.
Fenugreek and chromium are both commonly stacked for blood sugar and metabolic support, and each independently lowers fasting and postprandial glucose in human trials. Taken together they can produce a greater than expected drop in blood glucose. This is generally beneficial for people targeting glycemic control but can push at-risk individuals, especially those also on glucose-lowering medication such as insulin or sulfonylureas, into hypoglycemia (shakiness, sweating, dizziness, confusion).
Recommendation: For most healthy users the combination is fine and may be intentional for metabolic support. If you take diabetes medication or have a history of low blood sugar, monitor glucose more closely when starting both, and discuss dosing with your clinician. Typical doses are fenugreek 500 to 1000 mg standardized extract (or up to 5 g seed powder) and chromium 200 to 400 mcg daily. Take with meals to blunt postprandial spikes and reduce hypoglycemia risk between meals.
Combining niacin with chromium has been studied as a way to improve glucose handling. Controlled work in older adults found that niacin-bound or co-administered chromium produced greater improvements in glucose tolerance than chromium without niacin, consistent with niacin acting as part of the active chromium-nicotinate complex. This is generally a beneficial, additive relationship rather than a risk.
Recommendation: For people specifically targeting glucose metabolism, taking chromium (typically 200 to 1000 mcg/day) together with a modest niacin intake is reasonable and may modestly enhance chromium's glucose effect. No timing separation is needed; they can be taken in the same dose. People on diabetes medication should monitor blood glucose, since improved glucose handling can add to the effect of those drugs.
Numbered references. Citations throughout the page link here.
Vajdi M, Khajeh M, Safaei E et al.. Effects of chromium supplementation on body composition in patients with type 2 diabetes: A dose-response systematic review and meta-analysis of randomized controlled trials. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS). 2024
Umbrella review of 8 meta-analyses found no significant effect of chromium on TG, TC, LDL-c, or HDL-c. Subgroup analysis suggested chromium at doses >500 µg/day could significantly decrease triglycerides.
In 10 RCTs with 509 patients, chromium supplementation significantly reduced HbA1c but did not significantly improve fasting plasma glucose, triglycerides, total cholesterol, LDL, or HDL in type 2 diabetes patients.
Morvaridzadeh M, Estêvão MD, Qorbani M et al.. The effect of chromium intake on oxidative stress parameters: A systematic review and meta-analysis. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS). 2022
Feng C, Wuren Q, Zhang X et al.. Effects of dietary chromium picolinate supplementation on broiler growth performance: A meta-analysis. PloS one. 2021
Chromium supplementation significantly reduced FPG (-19 mg/dl), insulin (-12.35 pmol/l), HbA1C (-0.71%), and HOMA-IR (-1.53) in T2D patients
Significant reductions in weight (-0.75 kg), BMI, and body fat percentage, particularly for durations <=12 weeks and doses <=400 ug/d
White PE, Vincent JB. Systematic Review of the Effects of Chromium(III) on Chickens. Biological trace element research. 2019
Tang XL, Sun Z, Gong L. Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis. The journal of obstetrics and gynaecology research. 2018
Fazelian S, Rouhani MH, Bank SS et al.. Chromium supplementation and polycystic ovary syndrome: A systematic review and meta-analysis. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS). 2017
Chromium supplementation significantly improved glycemic control with HbA1c reduction of -0.55% and FPG reduction of -1.15 mmol/L, especially with chromium picolinate
Chromium supplementation produced statistically significant but small reductions in body weight; clinical relevance is uncertain
Chromium potentiates insulin action by enhancing insulin receptor signaling and GLUT4 transporter activity via chromodulin
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack